This Article Abstract Full Text Full Text (PDF) View Online Appendix Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Capucci, A. Search for Related Content PubMed PubMed Citation Articles by Capucci, A.

Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia Pacemakers

Alessandro Capucci, MD^_*,_*, Massimo Santini, MD, Luigi Padeletti, MD, Michele Gulizia, MD, GianLuca Botto, MD^||, Giuseppe Boriani, MD^¶, Renato Ricci, MD, Stefano Favale, MD^#, Francesco Zolezzi, MD^**, Natale Di Belardino, MD, Giulio Molon, MD, Fabrizio Drago, MD, Giovanni Q. Villani, MD^_*, Elena Mazzini, MS^||||, Marco Vimercati, MS^||||, Andrea Grammatico, PhD^|||| Italian AT500 Registry Investigators

^_* Cardiology Department, Civile Hospital, Piacenza, Italy
Cardiology Department, S. Filippo Neri Hospital, Rome, Italy
Cardiology Department, Clinica Medica, University of Florence, Florence, Italy
Cardiology Department, San Luigi-S. Currò Hospital, Catania, Italy
^|| Cardiology Department, S. Anna Hospital, Como, Italy
^¶ Institute of Cardiology, University of Bologna, Bologna, Italy
^# Cardiology Department, Policlinico Hospital, Bari, Italy
^** Cardiology Department, Civile Hospital, Vigevano, Italy
Cardiology Department, Civile Hospital, Velletri, Italy
Cardiology Department, S. Cuore Hospital, Negrar, Italy
Cardiology Department, Bambino Gesù Hospital, Rome, Italy
^|||| Clinical Department, Medtronic Italy, Milan, Italy

View larger version (17K): [in a new window]   Figure 1 Kaplan-Meier cumulative survival from embolic events.

View larger version (15K): [in a new window]   Figure 2 Kaplan-Meier cumulative survival from embolic events for patients with atrial fibrillation (AF) episodes longer than one day and for patients without AF recurrences or with AF episodes shorter than one day.